We use cookies to make sure our website better meets your expectations.
You can adjust your web browser's settings to stop accepting cookies. For further information, read our cookie policy.
SEARCH
IN Warsaw
Exchange Rates
Warsaw Stock Exchange - Indices
The Warsaw Voice » Business » February 5, 2018
You have to be logged in to use the ReadSpeaker utility and listen to a text. It's free-of-charge. Just log in to the site or register if you are not registered user yet.
Selvita wants millions
February 5, 2018   
Article's tools:
Print

Pawel Przewiezlikowski
Listed biotech firm Selvita wants to earmark the over PLN 134 million expected from its pending SPO for innovative projects in the field of oncology and for a molecular tools platform as well as expansion of its services offer and laboratory infrastructure, CEO Pawel Przewiezlikowski tells the daily Parkiet.
PLN 70 million worth of part of SPO receipts will go for financing the SEL120 project, which the firm wants to take to the second stage of clinical research this year, CEO adds. In 2018, Selvita wants to delegate operational responsibility for the SEL24 project to its Italian partner Menarini, Przewiezlikowski reveals. Selvita is too small a firm to venture a debut on a foreign market, CEO says. The company might, however, start to think about courting foreign investors once its capitalization hits several hundred million dollars and when the therapeutic potential of its molecules is confirmed, Przewiezlikowski adds.
© The Warsaw Voice 2010-2015
E-mail Marketing Powered by SARE